Skip to main content

Peer Review reports

From: Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

Original Submission
30 Sep 2021 Submitted Original manuscript
15 Apr 2022 Reviewed Reviewer Report
20 May 2022 Reviewed Reviewer Report
25 Jul 2022 Author responded Author comments - Yoshimasa Shiraishi
Resubmission - Version 2
25 Jul 2022 Submitted Manuscript version 2
3 Aug 2022 Reviewed Reviewer Report
12 Aug 2022 Author responded Author comments - Yoshimasa Shiraishi
Resubmission - Version 3
12 Aug 2022 Submitted Manuscript version 3
Publishing
2 Sep 2022 Editorially accepted
8 Sep 2022 Article published 10.1186/s12885-022-10056-x

You can find further information about peer review here.

Back to article page